Yili Chuannig Biotechnology Co (SZSE:301301) Construction In Progress : ¥649 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Construction In Progress?

Yili Chuannig Biotechnology Co's quarterly construction in progress increased from Sep. 2023 (¥356 Mil) to Dec. 2023 (¥538 Mil) and increased from Dec. 2023 (¥538 Mil) to Mar. 2024 (¥649 Mil).

Yili Chuannig Biotechnology Co's annual construction in progress declined from Dec. 2021 (¥96 Mil) to Dec. 2022 (¥60 Mil) but then increased from Dec. 2022 (¥60 Mil) to Dec. 2023 (¥538 Mil).

Yili Chuannig Biotechnology Co Construction In Progress Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Construction In Progress Chart

Yili Chuannig Biotechnology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

384.24

356.08

96.38

60.13

537.80

Yili Chuannig Biotechnology Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial											62.08	131.52	355.81	537.80	649.46

Yili Chuannig Biotechnology Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000

Website

http://www.klcnsw.com

Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines